Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Margins of Excision × Folfox protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 108 Colonic Neoplasms 48 Rectal Neoplasms 45 Carcinoma, Hepatocellular 24 Neoplasm Metastasis 22 Stomach Neoplasms 20 Pancreatic Neoplasms 9 Neoplasms 9 Cholangiocarcinoma 8 Adenocarcinoma Of Esophagus 7 Esophageal Neoplasms 6 Liver Neoplasms 5 Biliary Tract Neoplasms 5 Recurrence 4 Gastrointestinal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Esophageal Squamous Cell Carcinoma 3 Breast Neoplasms 3 Adenocarcinoma 3 Ovarian Neoplasms 2 Neurotoxicity Syndromes 2 Neoplastic Cells, Circulating 2 Gastrointestinal Diseases 2 Gallbladder Neoplasms 2 Digestive System Neoplasms 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Unresectable Metastatic Colorectal Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Prostatic Neoplasms 1

Interventions

Dermoscopy 2 varlilumab 1 Ultrasonography 1 Tumor Burden 1 Simvastatin 1 Radiosurgery 1 Observation 1 Neoadjuvant Therapy 1 Narrow Band Imaging 1 Microscopy, Confocal 1 Mastectomy, Segmental 1 Interferon alpha-2 1 Indocyanine Green 1 IFL protocol 1 Gastrectomy 1 Folfox protocol 1 Everolimus 1 Endoscopic Mucosal Resection 1 Drug Delivery Systems 1 Drug Combinations 1 Chemoradiotherapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04389086 2022-09-06

PelvEx II

Catharina Ziekenhuis Eindhoven

Phase 3 Recruiting

Gastrointestinal

Margins of Excision, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡